Although the role of Th17 in tumor progression remains controversial, the role of IL-23 in tumor incidence and metastasis was established in the mouse model. For example, mice lacking IL-23p19 were resistant to DMBA/TPA-induced skin papilloma [6] [7] . Recently, IL-23 was also reported to promote carcinogenesis and metastasis in the 3′-methylcholanthrene induced fibrosarcoma through suppressing the innate immune response [8] . However, the role of IL-23 in metastatic prostate cancer is unclear. In this study, we found that IL-23 was highly expressed in metastatic prostate cancer cells. We further proved that IL-23 could directly promote prostate cancer metastasis via a STAT3/ROR gamma signal, so we further explored the relationship between IL-23 and STAT3/ROR gamma in prostate metastasis. We found that IL-23 and STAT3/ROR gamma were highly correlated in metastatic prostate cancer cell lines directed. 
Interleukin 23 (IL-23) belongs to interleukin 6 super-family [1] . IL-12/23 p40 is the common subunit for them, which is covalently linked to either a p19 subunit to form IL-23 or a p35 subunit to form IL-12 [2] . Both cytokines are mainly expressed by activating dendrite cells or macrophages under the stimulation of pathogens. IL-23 was also reported to be secreted by tumor associated macrophages in tumor microenvironment [3] .
Interestingly, IL-23 spur different immune pathways [4] . IL-12 induces IFN-γ-producing Th1 cell development and enhances cytotoxic, anti-microbial and anti-tumor responses; whereas IL-23 expands Th17 cells, which is mainly involved in the pathology of autoimmunity and chronic inflammatory disease [5] .
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It is now well established that STAT3 signaling is a major intrinsic pathway driving apoptosis, inflammation, cellular transformation, survival, proliferation, invasion, angiogenesis and metastasis of cancer [10] [11] . However, compelling evidence has now shown that STAT3 is constitutively activated in many human cancers [12] . Indeed, many receptor-signaling pathways are. 
